These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3558169)
1. An experimental model for therapeutic trials of anthelminthic drugs. Mojon M; Saura C; Roojee N; Tran Manh Sung R J Antimicrob Chemother; 1987 Jan; 19(1):73-7. PubMed ID: 3558169 [TBL] [Abstract][Full Text] [Related]
2. Albendazole and thiabendazole in murine strongyloidiasis. Mojon M; Saura C; Roojee N; Tran Manh Sung R J Antimicrob Chemother; 1987 Jan; 19(1):79-85. PubMed ID: 3558170 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of albendazole against Strongyloides ratti and S. stercoralis in vitro, in mice, and in normal and immunosuppressed dogs. Grove DI; Lumsden J; Northern C J Antimicrob Chemother; 1988 Jan; 21(1):75-84. PubMed ID: 3356624 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052 [TBL] [Abstract][Full Text] [Related]
5. Effect of hygromycin B on migrating and adult Strongyloides ransomi in weanling pigs. Leland SE J Am Vet Med Assoc; 1972 Jan; 160(1):58-60. PubMed ID: 5008096 [No Abstract] [Full Text] [Related]
6. [The treatment of rats experimentally infected with Strongyloides venezuelensis by orally administered ivermectin]. Amato Neto V; Carignani FL; Matsubara L; Braz LM Rev Soc Bras Med Trop; 1997; 30(6):481-4. PubMed ID: 9463194 [TBL] [Abstract][Full Text] [Related]
7. Berberine: A nematocidal alkaloid from Argemone mexicana against Strongyloides venezuelensis. Elizondo-Luévano JH; Castro-Ríos R; López-Abán J; Gorgojo-Galindo O; Fernández-Soto P; Vicente B; Muro A; Chávez-Montes A Exp Parasitol; 2021 Jan; 220():108043. PubMed ID: 33197440 [TBL] [Abstract][Full Text] [Related]
8. [Observations on 35 cases of strongyloidiasis hospitalized at a clinical digestive disease unit]. Gherman I; Oproiu A; Aposteanu G; Constantinescu M; Cociaşu S; Pospai D; Enuică V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(2):169-78. PubMed ID: 2573131 [TBL] [Abstract][Full Text] [Related]
9. Effects of preintestinal larval antigenic stimuli on the generation of intestinal immunity in Strongyloides ratti infection in rats. Korenaga M; Nawa Y; Mimori T; Tada I J Parasitol; 1983 Feb; 69(1):78-82. PubMed ID: 6827449 [TBL] [Abstract][Full Text] [Related]
10. An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. Kotze AC; Clifford S; O'Grady J; Behnke JM; McCarthy JS Am J Trop Med Hyg; 2004 Nov; 71(5):608-16. PubMed ID: 15569793 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials with fenbendazole and oxibendazole for Strongyloides westeri infection in foals. Drudge JH; Lyons ET; Tolliver SC; Kubis JE Am J Vet Res; 1981 Mar; 42(3):526-7. PubMed ID: 7023296 [No Abstract] [Full Text] [Related]
12. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. Legarda-Ceballos AL; López-Abán J; Del Olmo E; Escarcena R; Bustos LA; Rojas-Caraballo J; Vicente B; Fernández-Soto P; San Feliciano A; Muro A Parasit Vectors; 2016 Jun; 9(1):364. PubMed ID: 27353595 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of ivermectin against somatic Strongyloides ransomi larvae. Barth D; Preston JM Vet Rec; 1985 Apr; 116(14):366-7. PubMed ID: 3838837 [TBL] [Abstract][Full Text] [Related]
14. Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis. Keiser J; Häberli C Parasit Vectors; 2021 Dec; 14(1):615. PubMed ID: 34949209 [TBL] [Abstract][Full Text] [Related]
15. The effects of 22, 23-dihydroavermectin B1 on Strongyloides ratti and S. stercoralis infections in mice. Grove DI Ann Trop Med Parasitol; 1983 Aug; 77(4):405-10. PubMed ID: 6688943 [TBL] [Abstract][Full Text] [Related]
16. Use of repeated measure linear modeling to analyze longitudinal data from experimental parasite infections. Paterson S J Parasitol; 2001 Oct; 87(5):969-71. PubMed ID: 11695417 [TBL] [Abstract][Full Text] [Related]
17. Larvicidal effects of several chemicals on Strongyloides infective larvae. Rebollo CD; Taira N; Ura S; Williams JC Vet Parasitol; 2003 Dec; 118(1-2):165-8. PubMed ID: 14651886 [TBL] [Abstract][Full Text] [Related]
18. Evaluating alternative compounds for strongyloidiasis therapy: Novel insights from larval migration inhibition test. Cambra-Pellejà M; Valderas-García E; Balaña-Fouce R; de la Vega J; Del Olmo E; Antwi-Ekwuruke J; Linnemann L; Heepmann L; Breloer M; Martínez-Valladares M PLoS Negl Trop Dis; 2024 Oct; 18(10):e0012532. PubMed ID: 39374184 [TBL] [Abstract][Full Text] [Related]
19. Strongyloides ratti: susceptibility to infection and resistance to reinfection in inbred strains of mice as assessed by excretion of larvae. Dawkins HJ; Grove DI; Dunsmore JD; Mitchell GF Int J Parasitol; 1980 Apr; 10(2):125-9. PubMed ID: 7372395 [No Abstract] [Full Text] [Related]
20. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]